| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef70b43d229e99fa27d7991a26b6add9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3f4111205626392f051303e7b8819 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2017-09-26^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebbf4458f126dc401fd21f595bbdce16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab9ae28103a3eceea4c3e90559a3b6c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24ac689a314060ca224c849d2e78f575 |
| publicationDate |
2019-04-03^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190035207-A |
| titleOfInvention |
Composition comprising inhibitors of miR-210 for inhibiting age-related metabolic disease and its screening method |
| abstract |
The present invention relates to a composition for inhibiting aging-related metabolic diseases and a method for screening miR-210 inhibitors comprising the miR-210 inhibitor as an active ingredient. More particularly, the present invention relates to a composition for inhibiting the expression or function of miR- And an amount of an ATG7 protein mediated by miR-210, wherein the expression level of miR-210 is at least one selected from the group consisting of: < RTI ID = 0.0 > The present invention relates to a method of screening for an inhibitor of aging-related metabolic diseases, which comprises the step of inhibiting ATG7 expression inhibition, , And the screening method of the present invention inhibits the inhibition of ATG7 expression by miR-210 in the hypothalamic arcuate nucleus, There may be screened for a substance that induces the torch to prevent aging-related metabolic disorders, and is useful for screening of anti aging-related metabolic disorders substances. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220125889-A |
| priorityDate |
2017-09-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |